PL2423315T3 - Sposób osiągania lepszej ekspresji polipeptydu - Google Patents

Sposób osiągania lepszej ekspresji polipeptydu

Info

Publication number
PL2423315T3
PL2423315T3 PL11163033T PL11163033T PL2423315T3 PL 2423315 T3 PL2423315 T3 PL 2423315T3 PL 11163033 T PL11163033 T PL 11163033T PL 11163033 T PL11163033 T PL 11163033T PL 2423315 T3 PL2423315 T3 PL 2423315T3
Authority
PL
Poland
Prior art keywords
polypeptide expression
achieving improved
improved polypeptide
achieving
expression
Prior art date
Application number
PL11163033T
Other languages
English (en)
Inventor
Johannes Andries Roubos
Van Noël Nicolaas Maria Elisabeth Peij
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2423315T3 publication Critical patent/PL2423315T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL11163033T 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu PL2423315T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06076328 2006-06-29
EP11163033.1A EP2423315B1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression
EP07765439A EP2035561A1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression

Publications (1)

Publication Number Publication Date
PL2423315T3 true PL2423315T3 (pl) 2015-06-30

Family

ID=37199000

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11163033T PL2423315T3 (pl) 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu

Country Status (12)

Country Link
US (2) US8812247B2 (pl)
EP (2) EP2035561A1 (pl)
JP (1) JP5250850B2 (pl)
CN (1) CN101490262B (pl)
AU (1) AU2007263880A1 (pl)
BR (1) BRPI0713795B1 (pl)
CA (1) CA2657975A1 (pl)
DK (1) DK2423315T3 (pl)
EA (1) EA015925B1 (pl)
ES (1) ES2534282T3 (pl)
PL (1) PL2423315T3 (pl)
WO (1) WO2008000632A1 (pl)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260805A1 (de) * 2002-12-23 2004-07-22 Geneart Gmbh Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
EP2049661A4 (en) * 2006-08-04 2012-07-04 Pharmathene Inc RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE
EP2631295A3 (en) 2007-02-15 2014-01-01 DSM IP Assets B.V. A recombinant host cell for the production of a compound of interest
WO2009005564A2 (en) * 2007-06-29 2009-01-08 The Regents Of The University Of California Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same
WO2009030254A1 (en) * 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
EP2222854A1 (en) 2007-11-20 2010-09-01 DSM IP Assets B.V. Dicarboxylic acid production in a filamentous fungus
US9340804B2 (en) 2007-11-20 2016-05-17 Dsm Ip Assets B.V. Dicarboxylic acid production in eukaryotes
CA2714088A1 (en) * 2008-02-15 2009-08-20 Dsm Ip Assets B.V. Process for the production of a dicarboxylic acid
JP5625199B2 (ja) 2008-03-07 2014-11-19 ディーエスエム アイピー アセッツ ビー.ブイ. ペントース糖発酵細胞
CA2715147A1 (en) * 2008-03-07 2009-09-11 Dsm Ip Assets B.V. A pentose sugar fermenting cell
BRPI0908946A2 (pt) 2008-03-11 2018-02-27 Dsm Ip Assets Bv síntese de éster ou de tioéster de adipato
EP2252577A2 (en) 2008-03-11 2010-11-24 DSM IP Assets B.V. Preparation of 6-aminocaproic acid from 5-formylvaleric acid
EP2123767A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of epsilon-caprolactam via lysine cyclisation
EP2123768A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of (Z)-6,7-dihydro-1H-azepin-2(5H)-one
US9012187B2 (en) 2008-07-08 2015-04-21 Dsm Ip Assets B.V. Dicarboxylic acid production by fermentation at low pH
US8703463B2 (en) 2009-03-10 2014-04-22 Dsm Ip Assets B.V. Pregastric esterase and derivatives thereof
WO2010102982A1 (en) 2009-03-10 2010-09-16 Dsm Ip Assets B.V. Method for improving the yield of a polypeptide
EP2406384A2 (en) 2009-03-11 2012-01-18 DSM IP Assets B.V. Preparation of alpha-ketopimelic acid
WO2010118932A1 (en) 2009-04-15 2010-10-21 Dsm Ip Assets B.V. Dicarboxylic acid production process
WO2010121933A1 (en) 2009-04-22 2010-10-28 Dsm Ip Assets B.V. Process for the production of a recombinant polypeptide of interest
UA108853C2 (uk) 2009-07-10 2015-06-25 Спосіб ферментації галактози
WO2011009700A1 (en) 2009-07-22 2011-01-27 Dsm Ip Assets B.V. Improved host cell for the production of a compound of interest
KR101694572B1 (ko) 2009-07-24 2017-01-09 디에스엠 아이피 어셋츠 비.브이. N-아실 또는 n-구아니딜 보호된 1,4-뷰테인다이아민 전구체를 통한 1,4-뷰테인다이아민의 제조 방법
PL2470667T3 (pl) 2009-08-27 2018-04-30 Dsm Ip Assets B.V. Sposób wytwarzania kwasu dikarboksylowego na drodze fermentacji
AU2010291265A1 (en) 2009-09-03 2012-03-15 Dsm Ip Assets B.V. Baking enzyme composition as SSL replacer
US20120238722A1 (en) 2009-11-24 2012-09-20 Roquette Freres Sa Process for the crystallization of succinic acid
EP2336310A1 (en) 2009-12-16 2011-06-22 Isobionics B.V. Valencene synthase
CA2784861A1 (en) 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
JP5521236B2 (ja) * 2009-12-22 2014-06-11 独立行政法人産業技術総合研究所 発現予測装置および発現予測方法
WO2011100369A2 (en) * 2010-02-09 2011-08-18 The Trustees Of Columbia University In The City Of New York Methods for altering polypeptide expression and solubility
WO2011157717A1 (en) 2010-06-14 2011-12-22 Dsm Fine Chemicals Austria Nfg. Gmbh & Co Kg Novel polypeptides having nad(p)h oxidase activity and the use thereof
CA2803222A1 (en) 2010-07-01 2012-01-05 Dsm Ip Assets B.V. A method for the production of a compound of interest
JP5999565B2 (ja) 2010-07-14 2016-09-28 ディーピーエックス ホールディングス ビー.ブイ. (r)−選択的アミノ化
WO2012031910A2 (en) 2010-09-10 2012-03-15 Dsm Ip Assets B.V. Method for preparing alpha-ketopimelic acid by c1-elongation
US20130237698A1 (en) 2010-09-10 2013-09-12 Dsm Ip Assets B.V. Preparation of 6-aminocaproic acid from alpha-ketopimelic acid
BR112013006883A2 (pt) 2010-09-24 2016-06-07 Dsm Ip Assets Bv processo de produção de ácido dicarboxílico
EP2495304A1 (en) 2010-12-03 2012-09-05 DSM IP Assets B.V. Dicarboxylic acid production in a yeast cell
WO2012089613A1 (en) 2010-12-28 2012-07-05 Dsm Ip Assets B.V. Process to increase the production of a succinyl-coa derived compound
WO2012123429A1 (en) 2011-03-11 2012-09-20 Dsm Ip Assets B.V. Vector-host system
TW201245448A (en) 2011-04-01 2012-11-16 Dsm Ip Assets Bv Preparation of 5-formyl valeric acid from alpha-ketopimelic acid
EP2537926A1 (en) 2011-06-21 2012-12-26 Isobionics B.V. Valencene synthase
ES2616790T3 (es) 2011-07-01 2017-06-14 Dsm Ip Assets B.V. Proceso para producir ácidos dicarboxílicos empleando células fúngicas
WO2013010057A1 (en) * 2011-07-13 2013-01-17 Aemetis, Inc. Compositons and methods for the production of isoprene
WO2013007821A1 (en) 2011-07-14 2013-01-17 Dsm Ip Assets B.V. Screening method
AR087423A1 (es) 2011-08-04 2014-03-19 Dsm Ip Assets Bv Celula capaz de fermentar azucares pentosas
EP2554668A1 (en) 2011-08-04 2013-02-06 DSM IP Assets B.V. A pentose sugar fermenting cell
BR112014016587A2 (pt) 2012-01-05 2020-10-27 Novartis Ag células fúngicas filamentosas deficientes de protease e métodos de uso das mesmas
EP2620496B1 (en) 2012-01-30 2015-06-03 DSM IP Assets B.V. Alpha-amylase
JP6224077B2 (ja) 2012-04-17 2017-11-01 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 改変された核酸を用いてポリペプチドを発現させるための方法
DK2852610T3 (en) 2012-05-23 2018-09-03 Glykos Finland Oy PRODUCTION OF FUCOSYLED GLYCOPROTEIN
US20150147365A1 (en) 2012-05-31 2015-05-28 Dsm Ip Assets B.V. Oral preparation
WO2014014339A2 (en) 2012-07-18 2014-01-23 Isobionics B.V. Rhodobacter for preparing terpenoids
EP3327112B1 (en) 2012-07-19 2020-02-12 DSM IP Assets B.V. Agse-deficient strain
DK2877576T3 (da) 2012-07-24 2019-08-12 Bp Corp North America Inc Xyloseisomeraser og anvendelser deraf
IN2015DN01041A (pl) 2012-08-28 2015-06-26 Dsm Ip Assets Bv
WO2014033019A1 (en) 2012-08-28 2014-03-06 Dsm Ip Assets B.V. Yeast strains engineered to produce ethanol from acetate
EP2898076B1 (en) 2012-09-19 2018-03-07 DSM IP Assets B.V. Cell modification method using essential genes as markers and optionally recycling these
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression
PL2909305T3 (pl) 2012-10-16 2019-06-28 Dsm Ip Assets B.V. Komórki o ulepszonej konwersji pentozy
WO2014142647A1 (en) 2013-03-14 2014-09-18 Wageningen Universiteit Fungals strains with improved citric acid and itaconic acid production
WO2015004241A2 (en) 2013-07-10 2015-01-15 Novartis Ag Multiple proteases deficient filamentous fungal cells and methods of use thereof
CN105764526B (zh) 2013-08-26 2020-12-15 生物技术研发公司 编码抗唾液酸化路易斯a抗原的人抗体的核酸
AR097480A1 (es) 2013-08-29 2016-03-16 Dsm Ip Assets Bv Células de levadura convertidoras de glicerol y ácido acético con una conversión de ácido acético mejorada
EP3077517B1 (en) 2013-12-02 2018-10-17 DSM IP Assets B.V. Ice structuring protein
MX375798B (es) 2014-05-19 2025-03-07 Dsm Ip Assets Bv Endoproteasa específica para prolina.
WO2015177152A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
WO2015177153A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
US9856324B2 (en) 2014-06-04 2018-01-02 MabVax Therapeutics, Inc. Human monoclonal antibodies to ganglioside GD2
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
EP3242948B1 (en) 2015-01-06 2021-12-22 DSM IP Assets B.V. A crispr-cas system for a yarrowia host cell
US10619170B2 (en) 2015-01-06 2020-04-14 Dsm Ip Assets B.V. CRISPR-CAS system for a yeast host cell
DK3242950T3 (da) 2015-01-06 2021-12-20 Dsm Ip Assets Bv Crispr-cas-system til en trådformet svampeværtscelle
WO2016131818A1 (en) 2015-02-16 2016-08-25 Dsm Ip Assets B.V. Process for producing itaconic acid under anaerobic conditions
AR104205A1 (es) 2015-04-09 2017-07-05 Dsm Ip Assets Bv Fosfolipasa c
AU2016273208B2 (en) 2015-06-02 2021-01-21 Dsm Ip Assets B.V. Use of ice structuring protein AFP19 expressed in filamentous fungal strains for preparing food
US10724040B2 (en) 2015-07-15 2020-07-28 The Penn State Research Foundation mRNA sequences to control co-translational folding of proteins
WO2017050652A1 (en) 2015-09-25 2017-03-30 Dsm Ip Assets B.V. Asparaginase
EP4361240A3 (en) 2015-11-17 2024-07-31 DSM IP Assets B.V. Preparation of a stable beer
WO2017201731A1 (en) 2016-05-27 2017-11-30 Beijing Vdjbio Co., Ltd. Antibodies, composition and kits comprising same, and methods of use thereof
US10829748B2 (en) 2016-06-10 2020-11-10 Dsm Ip Assets B.V. Mutant lipase and use thereof
US10787649B2 (en) 2016-07-13 2020-09-29 Dsm Ip Assets B.V. Malate dehyrogenases
WO2018013821A1 (en) 2016-07-13 2018-01-18 Dsm Ip Assets B.V. A crispr-cas system for an algal host cell
WO2018019948A1 (en) 2016-07-29 2018-02-01 Dsm Ip Assets B.V. Polypeptides having cellulolytic enhancing activity and uses thereof
CN106650307B (zh) * 2016-09-21 2019-04-05 武汉伯远生物科技有限公司 一种基于密码子对使用频度的基因密码子优化方法
FI3516056T3 (fi) 2016-09-23 2025-02-28 Dsm Ip Assets Bv Opas-rna:n ilmentämisjärjestelmä isäntäsolulle
WO2018114912A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114940A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
US10918113B2 (en) 2016-12-21 2021-02-16 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114938A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
EP3559217A1 (en) 2016-12-22 2019-10-30 DSM IP Assets B.V. Glutathione reductase
WO2018148761A1 (en) * 2017-02-13 2018-08-16 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for multiplexed trackable genomically-engineered polypeptides
NL2018457B1 (en) 2017-03-02 2018-09-21 Isobionics B V Santalene Synthase
EP3596199A1 (en) 2017-03-13 2020-01-22 DSM IP Assets B.V. Zinc binuclear cluster transcriptional regulator-deficient strain
CN107353327A (zh) * 2017-03-30 2017-11-17 南京百斯杰生物工程有限公司 植酸酶在黑曲霉中表达
US20200032252A1 (en) 2017-04-06 2020-01-30 Dsm Ip Assets B.V. Self-guiding integration construct (sgic)
CN110070913B (zh) * 2017-07-25 2023-06-27 南京金斯瑞生物科技有限公司 一种基于免疫算法的密码子优化方法
NL2019473B1 (en) 2017-09-01 2019-03-11 Isobionics B V Terpene Synthase producing patchoulol and elemol, and preferably also pogostol
PL3688149T3 (pl) 2017-09-26 2025-03-24 Bunge Global Innovation, Llc. Enzymatyczne usuwanie substratów chlorofilowych z olejów na bazie triacyloglicerolu
US11707522B2 (en) 2017-10-13 2023-07-25 Boehringer Ingelheim International Gmbh Human antibodies to Tn antigen
CN111492059A (zh) 2017-12-20 2020-08-04 帝斯曼知识产权资产管理有限公司 在宿主细胞中进行基因组编辑的方法
MX429191B (es) 2018-04-05 2025-11-13 Dsm Ip Assets Bv Alfa-amilasa maltogénica variante.
WO2019215102A1 (en) 2018-05-09 2019-11-14 Dsm Ip Assets B.V. Crispr transient expression construct (ctec)
US20230080079A1 (en) 2018-05-18 2023-03-16 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2019219904A2 (en) 2018-05-18 2019-11-21 Dsm Ip Assets B.V. Mutant lipase and use thereof
BR112020025589A2 (pt) 2018-06-19 2021-03-23 Dsm Ip Assets B.V. variantes de enzima lipolítica
SG11202011455SA (en) * 2018-07-30 2020-12-30 Nanjing Genscript Biotech Co Ltd Codon optimization
JP2021536049A (ja) * 2018-08-15 2021-12-23 ザイマージェン インコーポレイテッド 生物学的配列選択によるバイオリーチャブル予測ツール
CA3106384A1 (en) 2018-11-02 2020-05-07 Beijing Vdjbio Co., Ltd. Modified ctla4 and methods of use thereof
US12365885B2 (en) 2018-11-15 2025-07-22 Dsm Ip Assets B.V. Production of riboflavin
EP3891281A1 (en) 2018-12-05 2021-10-13 DSM IP Assets B.V. Crispr guide-rna expression strategies for multiplex genome engineering
EP3946720A1 (en) 2019-03-27 2022-02-09 Bunge Global Innovation, LLC. Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
MX2021011757A (es) * 2019-03-28 2021-12-10 Intellia Therapeutics Inc Polinucleótidos, composiciones y métodos para la expresión de polipéptidos.
BR112021025806A2 (pt) 2019-06-28 2022-02-08 Hoffmann La Roche Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster
EP3766982A1 (en) 2019-07-18 2021-01-20 Delft Advanced Biofuels B.V. Integrated system for biocatalytically producing and recovering an organic substance
CN110491447B (zh) * 2019-08-05 2021-08-17 浙江省农业科学院 一种用于异源基因体外表达的密码子优化方法及应用
CN110873833B (zh) * 2019-12-10 2022-04-08 国网河南省电力公司洛阳供电公司 一种含分布式电源的配电网自适应故障区段定位方法
BR112022017482A2 (pt) 2020-03-10 2022-10-18 Dsm Ip Assets Bv Pó lácteo com lactose reduzida
EP4015626A1 (en) 2020-12-18 2022-06-22 Isobionics B.V. Enzymes and methods for fermentative production of monoterpene esters
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
JP2022155412A (ja) * 2021-03-30 2022-10-13 国立大学法人 奈良先端科学技術大学院大学 植物へ導入する遺伝子の人工配列の設計システム
US20240218385A1 (en) 2021-04-21 2024-07-04 Zhejiang University Negative-strand rna viral vector and plant genome editing method without transformation
EP4355762A1 (en) 2021-06-17 2024-04-24 DSM IP Assets B.V. Improved bacillus host cell
JP2024528957A (ja) 2021-08-02 2024-08-01 ビーエーエスエフ ソシエタス・ヨーロピア イオニリデンエタンシンターゼによる新規な芳香化合物の生成
TW202440647A (zh) 2021-11-19 2024-10-16 英商米羅比奧有限公司 經工程改造之pd-1抗體及其用途
WO2023196866A1 (en) 2022-04-06 2023-10-12 Mirobio Limited Engineered cd200r antibodies and uses thereof
EP4525626A1 (en) 2022-05-16 2025-03-26 DSM IP Assets B.V. Lipolytic enzyme variants
DE102022118459A1 (de) * 2022-07-22 2024-01-25 Proteolutions UG (haftungsbeschränkt) Verfahren zur optimierung einer nukleotidsequenz für die expression einer aminosäuresequenz in einem zielorganismus
WO2024051806A1 (zh) * 2022-09-09 2024-03-14 南京金斯瑞生物科技有限公司 一种设计人源化抗体序列的方法
EP4365192A1 (en) 2022-11-04 2024-05-08 DSM IP Assets B.V. Microbial production of growth factors
EP4743572A1 (en) 2023-07-11 2026-05-20 DSM IP Assets B.V. ARGININE PROTEIN DEIMINASE
CN122121750A (zh) 2023-11-08 2026-05-29 帝斯曼知识产权资产管理有限公司 改良的酶变体
WO2025099225A1 (en) 2023-11-08 2025-05-15 Dsm Ip Assets B.V. Improved enzyme variants
WO2025144785A2 (en) 2023-12-28 2025-07-03 Dsm Ip Assets B.V. Cells and methods for the production of glycosylated compounds
WO2026003190A1 (en) 2024-06-27 2026-01-02 Basf Se Means and methods for alpha-farnesene production
EP4737565A1 (en) 2024-10-31 2026-05-06 Isobionics B.V. Utilization of sucrose for increased production of terpenes in rhodobacter microbial cell factories
CN121506296B (zh) * 2025-11-11 2026-07-03 深圳普罗吉医药科技有限公司 一种人白蛋白的密码子序列优化方法和装置

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
EP0340878B1 (en) 1988-05-06 2001-05-16 Aventis Pharma S.A. Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
US5082767A (en) 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
DK0635574T3 (da) 1993-07-23 2003-08-11 Dsm Ip Assets Bv Selektionsmarkørgenfri rekombinantstammer, en fremgangsmåde til fremstilling af disse og anvendelse af disse stammer
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
AU3802595A (en) 1994-11-08 1996-05-31 Novo Nordisk A/S Tripeptidyl aminopeptidase
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
ATE317005T1 (de) 1996-03-27 2006-02-15 Novozymes As Alkaline-phosphatase-defiziente, filamentöse pilze
PL336345A1 (en) 1997-04-11 2000-06-19 Dsm Nv Genic conversion as a tool for constructing recombined filiform fungi
CA2296067C (en) * 1997-07-09 2008-10-07 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
ES2287989T3 (es) 1997-12-22 2007-12-16 Dsm Ip Assets B.V. Clonacion de expresion en hongos filamentosos.
ES2317706T3 (es) 1998-12-23 2009-04-16 Novozymes A/S Metodo para produicir polipeptidos en celulas mutantes de aspergillus.
CN1195058C (zh) 1999-02-22 2005-03-30 诺维信公司 草酰乙酸水解酶缺陷型真菌宿主细胞
CN102174535B (zh) 2000-03-14 2014-04-09 诺维信公司 在制备多肽的方法中有效的真菌转录激活因子
WO2001072783A2 (en) 2000-03-24 2001-10-04 Genencor International, Inc. Production of secreted proteins by recombinant eukaryotic cells
NZ526101A (en) 2000-12-22 2005-06-24 Janssen Pharmaceutica Nv Genes for drug target identification in yeast and fungi i.e. candida that are involved in apoptosis
US6749945B2 (en) 2001-01-29 2004-06-15 The Board Of Regents For Oklahoma State University Advanced composite ormosil coatings
EP1231272A3 (en) 2001-02-08 2002-11-13 Laboratorios Ovejero S.A. Procedure for obtaining bovine chymosin (rennin), curd
WO2003070957A2 (en) 2002-02-20 2003-08-28 Novozymes A/S Plant polypeptide production
EP1490494A1 (en) * 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
EP1590444A2 (en) 2003-02-05 2005-11-02 DSM IP Assets B.V. Use of oxalate deficient aspergillus niger strains for producing a polypeptide
DK1613761T3 (da) 2003-03-31 2009-12-14 Novozymes Inc Fremgangsmåder til fremstilling af biologiske stoffer i enzymdefekte mutanter af Aspergillus niger
CA2559827A1 (en) 2004-04-02 2005-10-13 Dsm Ip Assets B.V. Filamentous fungal mutants with improved homologous recombination efficiency
CA2560205A1 (en) 2004-04-16 2005-10-27 Dsm Ip Assets B.V. Fungal promoters for expressing a gene in a fungal cell
CA2568788A1 (en) 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
EP1799827A2 (en) 2004-10-12 2007-06-27 DSMIP Assets B.V. Fungal transcriptional activators useful in methods for producing a polypeptide
EP1799829B1 (en) 2004-10-15 2012-01-18 DSM IP Assets B.V. Method for production of a compound in a eukaryotic cell
DK2410048T3 (en) 2005-01-24 2016-11-28 Dsm Ip Assets Bv A process for the preparation of a compound of interest in a filamentous fungal cell

Also Published As

Publication number Publication date
EA200900096A1 (ru) 2009-06-30
JP5250850B2 (ja) 2013-07-31
US20090286280A1 (en) 2009-11-19
EA015925B1 (ru) 2011-12-30
EP2423315B1 (en) 2015-01-07
EP2423315A1 (en) 2012-02-29
CN101490262A (zh) 2009-07-22
WO2008000632A1 (en) 2008-01-03
CA2657975A1 (en) 2008-01-03
JP2009540845A (ja) 2009-11-26
EP2035561A1 (en) 2009-03-18
BRPI0713795B1 (pt) 2018-03-20
US8812247B2 (en) 2014-08-19
BRPI0713795A2 (pt) 2012-11-06
AU2007263880A1 (en) 2008-01-03
DK2423315T3 (en) 2015-04-13
US20140377800A1 (en) 2014-12-25
CN101490262B (zh) 2012-09-26
ES2534282T3 (es) 2015-04-21

Similar Documents

Publication Publication Date Title
IL196496A (en) A method for producing recombinant protein
GB0625995D0 (en) Method for preparing a composition
ZA200904317B (en) Improved method for making analgesics
IL197221A (en) Method for cleaning up protein
IL201391A0 (en) Method for stabilizing a protein
GB0601961D0 (en) Method
GB0603081D0 (en) Method
GB0607317D0 (en) Method
GB0606147D0 (en) Method
IL197979A0 (en) Method for peptide synthesis
GB0724491D0 (en) A method
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
GB0603008D0 (en) Method
GB0605323D0 (en) Method
IL193248A0 (en) A method for producing o-methyl-n-nitroisourea
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
GB0606954D0 (en) Method
GB0611391D0 (en) Method
TWI340345B (en) Method for selecting critical variables
GB0603036D0 (en) Method
GB0612342D0 (en) Method
GB0612014D0 (en) Method
GB0610949D0 (en) Method